Pharmaceuticals

We have developed and validated analytical methods for occupational hygiene samples for over 30 pharmaceutical actives including thiamine hydrochloride, taxmoxifen citrate, tacrolimus, pioglitazone hydrochloride, hydrochlorothiazide, candesartan cilexetil, tamulosin, famotidine, solifenacin succinate, S-isoquinoline, R-modafinal, mirabegon, spironolactone, ethinyloestradiol and norethisterone.


The validation process includes identifying appropriate sampling media and efficiency of recovery, sample stability, detection limits and analytical uncertainty.

We also provide routine analysis of occupational hygiene samples for substances for which validations have been undertaken as well as providing analysis for a wide range of other substances used in the pharmaceutical industry.


Related services include occupational hygiene monitoring and the provision of advice on in-house occupational exposure limits (OELs) for the pharmaceutical industry. We have developed OELs for well over 100 different actives for a number of clients in the pharmaceutical sector. Most of these have been substances that are in routine production but some have been for substances that are currently undergoing development and testing or substances used as starting materials or intermediates in the production process.

Contact: Carolyn McGonagle, 0131 449 8000, carolyn.mcgonagle@iom-world.org

We're here to provide you with more information and answer any questions you may have. Contact us
  • IOMworld Posted: yesterday
    RT @IOMworld: With support from the Asbestos Research Council and the Colt Foundation, IOM carried out a 20-year program of ground-breaking…
  • IOMworld Posted: 8 days ago
    RT @IOMworld: We conducted research funded by the Department for Environment, Food & Rural Affairs that measured real-life pesticide exposu…
  • IOMworld Posted: 9 days ago
    RT @JohnCherrie: Around 4500 workers in India will die from #mesothelioma caused by past exposure to asbestos in #ship recycling yards. Rea…
  • IOMworld Posted: 9 days ago
    RT @claire_horwell: New paper just out (pre-proof): “Community perceptions of protective practices to prevent ash exposures around #Sakuraj
  • IOMworld Posted: 12 days ago
    RT @UKRI_News: . @IOMworld will find ways for the public to contribute to #AirPollution research by monitoring their local area: one of 53…
  • IOMworld Posted: 15 days ago
    RT @IOMworld: Remember, the best way to keep up to date with our #IOM50 poster campaign is on our brand new Instagram account, @iomworld.…
  • IOMworld Posted: 17 days ago
    RT @ONS: Today is #NationalSickieDay when lots of people allegedly take a day off sick 🤒. In 2018, 141.4 million days were lost through sic…
  • IOMworld Posted: 17 days ago
    RT @journal_occmed: This study assessed if attendance on a occupational medicine distance learning course changed students' recognition and…
  • IOMworld Posted: 17 days ago
    RT @H_S_E: If you’re an employer, you should be aware that new evidence shows exposure to mild steel welding fume can cause cancer. Ensure…
  • IOMworld Posted: 17 days ago
    RT @BOHSworld: During #tinnitusweek and as founding members of the @uk_hearing we support its mission to prevent damage to our nation’s hea…
  • Contact Us

If you would like to contact us, please use the attached form and we will get back to you. Alternatively, call or write to us at our Head Office in Edinburgh or one of our regional offices.

Our office hours are: 

Monday to Friday - 8.00am to 5.15pm

Our head office numbers is +44 (0)131 449 8000

Email: info@iom-world.org